Shah Gaurav 4
4 · ROCKET PHARMACEUTICALS, INC. · Filed Nov 20, 2025
Insider Transaction Report
Form 4
Shah Gaurav
CEO
Transactions
- Sale
Common Stock
2025-11-18$2.98/sh−6,276$18,721→ 778,296 total
Holdings
- 207,897(indirect: By Spouse)
Common Stock
- 198,341(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.